De Luca, Giuseppe2; Verdoia, Monica3; Dirksen, Maurits T3; Spaulding, Christian3; Kelbæk, Henning Skov4; Schalij, Martin3; Thuesen, Leif5; Hoeven, Bas van der3; Vink, Marteen A3; Kaiser, Christoph3; Musto, Carmine3; Chechi, Tania3; Spaziani, Gaia3; Diaz de la Llera, Luis Salvador3; Pasceri, Vincenzo3; Di Lorenzo, Emilio3; Violini, Roberto3; Suryapranata, Harry3; Stone, Gregg W3
1 Department of Clinical Medicine - The Department of Cardiological Medicine B, Department of Clinical Medicine, Health, Aarhus University2 Division of Cardiology, Ospedale "Maggiore della Carità", Eastern Piedmont University, Novara, Italy. firstname.lastname@example.org unknown4 Institut for Klinisk Medicin5 The Department of Cardiological Medicine B, Faculty of Health Sciences, Aarhus University, Aarhus University
insights from the DESERT cooperation
Several studies have found that among patients with ST-segment elevation myocardial infarction (STEMI) treated by thrombolysis, female sex is associated with a worse outcome. However, still controversial is the prognostic impact of gender in primary angioplasty, especially in the era of drug-eluting stents (DES). Therefore, the aim of this study was to investigate sex-related differences in clinical outcome in patients with STEMI treated with primary angioplasty with Bare-Metal Stent (BMS) or DES.